Writing and Research

Please see my CV and Google Scholar for an updated list of research presentations and publications.

This Site:

June 2022 - TechBio
May 2022 - Recent Science
April 2022 - Arcellx S-1
March 2022 - Rheumatic Diseases
February 2022 - Doing a PhD in 2022
February 2022 - Reflections on Undergrad
January 2022 - But Big Pharma Bad
January 2022 - A Post on Vaccines
December 2021 - Year in Review: 2021
December 2021 - ASH2021
December 2021 - NK
November 2021 - Tregs
November 2021 - Cell Therapy Infrastructure
October 2021 - Advice
September 2021 - Neoleukin Therapeutics
August 2021 - Engineering Gene Therapy
July 2021 - Lyell and ARCH style investing
July 2021 - Biotech Failures
June 2021 - Relay S-1
June 2021 - Ideology
May 2021 - Fantastic Papers and Where to Find Them
April 2021 - Imagining the Future of Cancer Therapy
April 2021 - CAR-T
March 2021 - Atlanta
March 2021 - Misaligned Incentives in Bio VC
February 2021 - Recursion Pharmaceuticals
January 2021 - Meta Science Thoughts
December 2020 - Why Science Doesn’t Need More Hype
December 2020 - Synbio Cellular Devices
December 2020 - What Happened in 2020
November 2020 - How Moderna made the vaccine
October 2020 - Spotify Analysis
September 2020 - Drug Repurposing
August 2020 - CRISPR: Frontiers in Gene Therapy
August 2020 - Reflections on Alix Ventures: My Time as a Summer Venture Fellow
July 2020 - Quantum Enabled Drug Development: A New Use Case for Quantum Computing
July 2020 - Leadership: Effectively Leading Teams
June 2020 - AI Powered Drug Discovery: A New Paradigm for Drug Development
June 2020 - Twitter Gems: Random Internet Tidbits
May 2020 - Longevity Startups: Market Introduction
May 2020 - Multi-Omics: Challenges and New Approaches
April 2020 - Random Thoughts From April: University Endowments and COVID-19 Losses
April 2020 - Random Thoughts From April: 5 Random Topics
April 2020 - Experiential Learning: Notes on Student Startups
April 2020 - What is Value?: A First Principles Approach
April 2020 - COVID-19: Notes on Recovering Flow State
March 2020 - The New Hematologist Oncologist: Notes on Ultra-Specialization in College
February 2020 - Narrative Violation: Notes on Developing Anti-Herd Mentality
January 2020 - 10,000 Games of Blitz Chess: Lessons Learned From My Favorite Game
December 2019 - Strong Opinions Loosely Held: 11 Takes on the World
November 2019 - Andreessen Horowitz’s Investment in Tmunity
October 2019 - What I Wish I Did In High School: Reflections on 4 Years in a Baltimore City High School
September 2019 - Linear Mixed Effect Modeling for Fantasy Football: Applying Statistical Modeling to Fantasy Football

Alix Ventures:

During the coronavirus summer of 2020, I had the pleasure of leading content at Alix Ventures, an early stage healthcare and life sciences VC firm based in San Francisco. During my time, I doubled follower count, tripled views, and earned the publication the distinction as a top writer in venture capital. In all, I was able to write, edit, and publish 24 articles and reports - all linked below!

Market Deep Dive Reports (pdfs)

AI Drug Discovery | Quantum Enabled Drug Development | CRISPR Therapeutics | Longevity Therapeutics | Drug Repurposing

Founder Spotlight Series: Interviews with top early stage biotech founders

Zachary Sun of Tierra Biosciences | Caralynn Collens of Dimension Inx | Rust Felix of Slope | Xiling Shen of Xilis | Evan Ehrenberg and Sol Chen of Clara Health | Lucas Siow of ProteinQure | Jack O’Meara of Ochre Bio

Feature Articles

The Biology of Business | Tackling Market Forces in Healthcare and Life Sciences | Frontier Perspectives: Quantum Aided Drug Development | Frontier Perspectives: AI Drug Discovery | Frontier Perspectives: CRISPR Therapeutics | Time Capsule: 50 Years in Biotech | Frontier Perspectives: Drug Repurposing

Podcast Episodes and Show Notes

Mark Pulido - Former CEO @ McKesson and Novartis | Rob Chess - Chairman @ Twist Biosciences and Nektar Therapeutics | Jessica Chao - Director @ UCSF Clinical Innovations Center | Tony Kulesa - Co-Founder @ Petri Life Sciences Accelerator | Ian Tong - CMO @ Doctor on Demand | Nan Li - Managing Partner @ Obvious Ventures